U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07736547) titled 'AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss' on July 24.
Brief Summary: AIM-WEIGHT is a clinical study evaluating whether a fixed microbiome-targeted nutritional supplement can support weight loss in adults with overweight or obesity who do not have prediabetes or diabetes. The formulation was developed using an artificial-intelligence-guided analysis of gut microbiome and metabolic-health data. The AI system will not select or modify treatment for individual participants during the study.
Eighty participants will be randomly assigned to receive either the active nutritional supplement or a ma...